ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » ARNA Stock Price » ARNA Stock News

Arena Share News

 Arena Pharmaceuticals (mm) Stock Price
ARNA Stock Price
 Arena Pharmaceuticals (mm) Stock Chart
ARNA Stock Chart
 Arena Pharmaceuticals (mm) Stock News
ARNA Stock News
 Arena Pharmaceuticals (mm) Company Information
ARNA Company Information
 Arena Pharmaceuticals (mm) Stock Trades
ARNA Stock Trades

Arena Pharma Finance Chief Hoffman To Leave Company

DOW JONES NEWSWIRES Arena Pharmaceuticals Inc. (ARNA) said its Chief Financial Officer Robert Hoffman has taken a new position in the health-care industry and will leave the company after it reports its full-year 2010 results. Hoffman is a veteran of the biopharmaceutical company, having served as CFO since December of 2005 and having been with the company since 1997. "Robert has built a strong finance team at Arena, and we are focused on ensuring a smooth transition when he departs next month," said President and Chief Executive Jack Lief. Arena said Jennifer Bielasz and Carolyn Felzer will "continue to play key leadership roles in Arena's finance department" in the interim. Arena in January said it planned to cut its U.S. work force by about one-fourth, or 66 employees, as the company continued to focus on regulatory approval of its proposed diet drug lorcaserin. The U.S. Food and Drug Administration had rejected the drug in October because of questions about its effectiveness, as well as the drug's association with breast-tumor growth in female rat studies. Shares of Arena closed at $1.66 and were inactive after hours. The stock has fallen 46% in the past year. -By Nathan Becker, Dow Jones Newswires; 212-416-2855; nathan.becker@dowjones.com;

Stock News for Arena (ARNA)
DateTimeHeadline
02/11/201611:00:58Schedule 13g<br /> (sc 13g/a)
02/10/201614:46:54Amended Statement of Ownership (sc 13g/a)
01/25/201613:50:21Amended Statement of Ownership (sc 13g/a)
01/13/201609:41:00U.S. Hot Stocks: Hot Stocks to Watch
01/12/201616:55:03Current Report Filing (8-k)
01/12/201616:05:00Boehringer Ingelheim and Arena Pharmaceuticals Collaborate to...
01/07/201608:00:00Arena Pharmaceuticals to Present at the 34th Annual J.P. Morgan...
12/04/201516:57:11Orexigen Therapeutics, Inc.'s Stock Loses Weight on Downgrade
12/04/201514:08:02Why Arena Pharmaceuticals, Inc. Bulked Up in November
12/03/201507:00:03Why Axovant Sciences Skyrocketed 56% in November
12/01/201517:05:24Current Report Filing (8-k)
12/01/201511:06:45Here's Why Arena Pharmaceuticals' Stock Briefly Spiked Today
12/01/201508:00:00Eisai and Arena Pharmaceuticals Announce Completion of Enrollment...
11/30/201519:40:38Why Ambarella, Arena Pharmaceuticals, and ITC Holdings Jumped...
11/30/201508:00:00Eisai and Arena Pharmaceuticals Announce FDA Acceptance of New...
11/24/201508:00:00Arena Pharmaceuticals to Present at Piper Jaffray 27th Annual...
11/19/201508:00:00Arena Pharmaceuticals to Host Analyst & Investor Day on December...
11/12/201511:00:033 Dangerous Stocks
11/10/201516:20:28Current Report Filing (8-k)
11/10/201516:00:00Arena Pharmaceuticals Reports Third Quarter 2015 Financial Results...

Arena Pharmaceuticals and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad